Taken together with the results of our current study, the findings suggest that sTNFR2 prevents the generation of macrophage-chemoattracting chemokines—such as CCL5—by the cancer cells; in this way, sTNFR2 may reduce the ability of the cancer cells to recruit deleterious tumor-associated macrophages to the tumor site. The gene discussed is CCL5; the disease is cancer.